Dec-07-17 Initiated
Maxim Group
Buy
$6
Jun-27-17 Initiated
Dawson James
Buy
Jun-26-17 Initiated
The Benchmark Company
Speculative Buy
$6
Sep-26-16 Initiated
Rodman & Renshaw
Buy
$6
Feb-16-21 04:45PM
Feb-11-21 07:26AM
Feb-10-21 11:00PM
Feb-06-21 11:52AM
Feb-05-21 09:00PM
Feb-04-21 03:45AM
Feb-03-21 06:00PM
Feb-01-21 05:16PM
Jan-30-21 07:06PM
Jan-28-21 06:15PM
04:02PM
Jan-16-21 02:54PM
Jan-14-21 05:27PM
Jan-09-21 10:29AM
Jan-07-21 04:06PM
04:05PM
Dec-19-20 04:17PM
Dec-18-20 10:28PM
Dec-08-20 12:12PM
Dec-07-20 04:54PM
Dec-01-20 07:14PM
Nov-30-20 08:50PM
Nov-18-20 08:00AM
Nov-17-20 12:10PM
Nov-13-20 10:37PM
Nov-12-20 05:31PM
04:25PM
12:25PM
Nov-02-20 04:00PM
Oct-28-20 09:55PM
05:54PM
Oct-20-20 12:30PM
Oct-19-20 03:24PM
Oct-14-20 07:00PM
01:14PM
Oct-13-20 08:20PM
Oct-09-20 08:01AM Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited PR Newswire
Oct-05-20 05:55PM
Oct-02-20 08:01PM
Sep-26-20 03:01AM
Sep-25-20 04:55PM Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN) PR Newswire
Sep-24-20 03:55PM
10:48AM
Sep-23-20 11:45PM
03:00PM
Sep-17-20 02:50PM
Sep-16-20 01:24PM Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX) GlobeNewswire
Sep-12-20 11:00AM
Sep-10-20 08:50PM Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings Limited PR Newswire
08:00AM
Sep-03-20 08:00AM
01:10AM
Sep-02-20 08:00PM
Sep-01-20 10:30PM
07:17PM
Aug-31-20 11:36AM
Aug-27-20 04:35PM
12:45PM
10:59AM
Aug-26-20 06:39PM Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings Limited PR Newswire -9.08%
06:09PM
Aug-25-20 06:10PM
03:00PM
10:21AM
08:38AM
06:20AM
Aug-24-20 05:58PM
03:41PM
08:00AM
Aug-14-20 07:30AM
Jun-24-20 05:30PM
Jun-01-20 08:00AM
May-12-20 06:37AM
Feb-20-20 09:00AM
Nov-20-19 08:00AM
Nov-14-19 05:29AM
Oct-24-19 04:15PM
08:30AM
Oct-17-19 06:55AM
Aug-20-19 08:00AM
Jul-16-19 12:44PM
08:44AM
Jul-15-19 04:22PM
04:10PM
Jun-25-19 07:24AM American City Business Journals
Jun-24-19 07:00AM
Jun-05-19 02:00AM
May-20-19 05:06PM
05:00PM
Apr-16-19 07:22AM
07:00AM
Mar-26-19 08:06AM
Feb-14-19 07:04AM
Jan-31-19 04:01PM
Jan-29-19 07:25AM
Jan-28-19 10:33PM
04:00PM
Jan-21-19 09:21AM
Jan-16-19 08:45AM
Jan-14-19 05:29PM
Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. The company's clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybridization probes targeting hematological, and human papillomavirus-associated cancers, which include cervical, anal, head, and neck cancers. It serves the biotechnology and pharmaceutical customers in the United States, Europe, and Australia. Cancer Genetics, Inc. was founded in 1999 and is headquartered in Rutherford, New Jersey.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite